The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)

NCT07190534 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Frontal Fibrosing Alopecia
Cicatricial Alopecia

Interventions

DRUG: Hydroxychloroquine (HCQ)
DRUG: Methotrexate (MTX)

Sponsor

Erasmus Medical Center